Skip to main content
LISATA THERAPEUTICS, INC. logo

LISATA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LSTA ISIN · US1280583022 LEI · 5493002287F62M3EGQ04 US Manufacturing
Open in API
Filings indexed 1,093 across all filing types
Latest filing 2011-07-01 Director's Dealing
Country US United States of America
Listing US LSTA

About LISATA THERAPEUTICS, INC.

https://www.lisata.com/

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Recent filings

Filing Released Lang Actions
Director's Dealing 2011
Director's Dealing
2011-07-01 English
Board/Management Information 2011
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 29, 2011, reporting the appointment of a new principal accounting officer, Joseph Talamo, including details about his background, compensation, and employment terms. The key section is Item 5.02, which pertains to the departure or appointment of directors or certain officers. There are no financial statements or detailed financial data presented, nor is this an announcement of a report publication. The content clearly fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2011-06-30 English
FORM 8-K/A AMENDMENT NO. 1
Audit Report / Information Classification · 95% confidence The document is a Form 8-K/A (Amendment No. 1) filed with the SEC, specifically a Current Report pursuant to the Securities Exchange Act of 1934. The content focuses on the change in the company's independent registered public accounting firm, including details about Deloitte & Touche LLP declining re-appointment and the company's process to select a new auditor. It includes a letter from Deloitte agreeing with the company's statements. There are no financial statements or substantive financial data presented, nor is this a full annual or interim report. The document is primarily an announcement about auditor changes, which fits the category of Audit Report / Information (AR) as it relates to auditor changes and related disclosures but is not a full annual report or audit report itself. Given the nature of the content and the regulatory context, the best classification is AR with high confidence.
2011-06-30 English
Regulatory Filings 2011
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 23, 2011, reporting a change in the company's independent registered public accounting firm. It details Deloitte & Touche LLP declining re-appointment and the company's process to select a new auditor. The content focuses on auditor changes and related disclosures, not on financial results, earnings, or annual reports. The document length is 4019 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. This fits the category of Regulatory Filings (RNS), as it is a general regulatory announcement about auditor changes and does not contain financial statements or detailed financial analysis. Therefore, the appropriate classification is RNS with high confidence.
2011-06-29 English
Regulatory Filings 2011
Regulatory Filings
2011-06-14 English
Investor Presentation 2011
Investor Presentation Classification · 95% confidence The document is a Form 8-K/A (amendment to a current report) filed with the SEC, dated June 13, 2011. It primarily provides a revised slide presentation correcting a typographical error in a previously filed Form 8-K. The document states that the slide presentation is furnished as an exhibit and is not "filed" for certain legal purposes. There is no substantive financial data or detailed report content; rather, it is an update or correction to a previously filed presentation. The document length is 4458 characters, which is relatively short and consistent with an announcement or furnishing of a presentation rather than a full report. Given these factors, the document fits best under the category of Investor Presentation (IP), as it involves a slide presentation intended for investors, furnished as an exhibit to a current report.
2011-06-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.